30 Mar 2018
In view of recent developments in the renewal process of the active substance chlorpropham under Regulation (EU) 1107/2009, we hereby give a short summary of the current status.
24 Nov 2017
CARY, N.C. (21 November 2017) – Arysta LifeScience, a Platform Specialty Products Company (NYSE: PAH), recently named Hildo Brilleman as the company’s chief executive officer of its Europe, Middle East & Africa (EMEA) region, effective January 1, 2018.
10 Nov 2017
CARY, N.C. and JOHNSTON, IOWA (7 November 2017) – Arysta LifeScience, a Platform Specialty Products Company (NYSE:PAH), recently announced that it has initiated a long-term global strategic collaboration with DuPont.
03 Jul 2017